Related Experiment Video
Updated: Jan 13, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
M6AREG 2.0: the landscape of m6A-centered crosstalk with diverse epigenetic regulation
Mengjie Yang1,2, Ying Zhou1,3, Liting Yang2
1The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Abstract:
m6A-centered crosstalk with epigenetic regulation (m6A-CT) is essential for understanding disease development and drug response. Based on different layers of epigenetic regulation, m6A-CT can be classified into four categories: m6A-centered crosstalk with histone modification (m6A-HistMod), m6A-centered crosstalk with DNA methylation (m6A-DNAMeth), m6A-centered crosstalk with RNA modification (m6A-RNAMod), and m6A-centered crosstalk with non-coding RNA (m6A-ncRNA). However, none of the existing databases has comprehensively provided the crucial data regarding m6A-CT. Therefore, a significant update was made to the M6AREG database. This updated version includes 713 entries for m6A-HistMod, 300 entries for m6A-DNAMeth, 483 entries for m6A-RNAMod, and 939 entries for m6A-ncRNA. These types of crosstalk can alter cellular pathways and processes, ultimately leading to the development of 271 categories of diseases and the response data of 205 drugs, which are regulated by 585 epigenetic regulators (including 138 regulatory proteins and 447 non-coding RNAs). Given that these data are critical for identifying diagnostic biomarkers and therapeutic targets, discovering drugs that target m6A modification, and developing combinatorial therapies to overcome drug resistance or immune evasion, this update will greatly enhance the impact of M6AREG and hold significant importance for m6A-relevant studies. The database is currently accessible to all users at: https://idrblab.org/m6areg/.
Insights
The M6AREG database now comprehensively includes m6A-centered crosstalk (m6A-CT) data, covering epigenetic regulation, diseases, and drug responses. This update enhances understanding of m6A-CT for biomarker discovery and therapeutic development.
Area of Science:
- Epigenetics and Molecular Biology
- RNA Biology
- Bioinformatics
Background:
- m6A-centered crosstalk (m6A-CT) with epigenetic regulation is crucial for disease development and drug response.
- Existing databases lack comprehensive m6A-CT data, hindering research.
- m6A-CT involves interactions with histone modifications, DNA methylation, RNA modifications, and non-coding RNAs.
Purpose of the Study:
- To update the M6AREG database with comprehensive m6A-CT data.
- To provide a centralized resource for m6A-CT, epigenetic regulators, associated diseases, and drug responses.
- To facilitate research in identifying diagnostic biomarkers, therapeutic targets, and drug discovery related to m6A modification.
Main Methods:
- Database update and curation of m6A-CT entries.
- Classification of m6A-CT into four categories: m6A-HistMod, m6A-DNAMeth, m6A-RNAMod, and m6A-ncRNA.
- Inclusion of data on 271 diseases and 205 drug responses regulated by 585 epigenetic regulators.
Main Results:
- The updated M6AREG database contains 713 m6A-HistMod, 300 m6A-DNAMeth, 483 m6A-RNAMod, and 939 m6A-ncRNA entries.
- The database links m6A-CT to 271 disease categories and 205 drug responses.
- Data on 585 epigenetic regulators (138 proteins, 447 non-coding RNAs) are integrated.
Conclusions:
- The enhanced M6AREG database provides critical data for m6A-CT studies.
- This resource is vital for identifying diagnostic biomarkers and therapeutic targets.
- The update supports drug discovery, combinatorial therapies, and overcoming drug resistance or immune evasion.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
07:50Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina
Published on: August 29, 2018
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Spreading of Chromatin Modifications
Writers
The writer...
Position-effect Variegation
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...